When tumor suppressor TGFβ meets the HER2 (ERBB2) oncogene

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Transforming growth factor beta (TGFβ) typically suppresses tumors in normal cells.
• However, in HER2-overexpressing breast cancer, TGFβ promotes cancer cell migration, invasion, and survival.
• This paradoxical role is linked to the oncogene HER2 (ERBB2; neu).

Purpose of the Study:

• To elucidate the molecular mechanisms of crosstalk between TGFβ and HER2 signaling in breast cancer.
• To understand how this interaction contributes to tumor progression and metastasis.
• To explore therapeutic strategies targeting this crosstalk.

Main Methods:

• Review of recent studies examining Smad-dependent and -independent mechanisms.
• Analysis of molecular crosstalk pathways involving TGFβ and HER2.
• Investigation of effects on cancer cell proliferation, survival, invasion, and metastasis.

Main Results:

• TGFβ loses its tumor-suppressive function in HER2-overexpressing cells due to altered Smad-mediated transcription.
• HER2 signaling confers pro-survival and pro-migratory functions to TGFβ.
• This crosstalk leads to increased proliferation, invasion, metastasis, and resistance to therapies.

Conclusions:

• The HER2-driven cellular context abrogates TGFβ's tumor suppressive role and activates its oncogenic functions.
• TGFβ signaling can potentiate oncogenic HER2 signaling through ligand shedding and integrin clustering.
• Targeting the TGFβ:HER2 crosstalk offers a potential strategy to inhibit breast cancer progression and metastasis.